Urgent

Nocardiosis

Nocardia · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Nocardia is a filamentous aerobic actinomycete causing pulmonary, cutaneous and disseminated (especially cerebral) infection, mainly in cell-mediated immunosuppression. CNS dissemination is common, so brain imaging is routine.

Red flags

  • Focal neurological deficit (cerebral abscess)
  • Disseminated disease with multi-organ involvement
  • Respiratory failure
  • Severe immunosuppression
  • Treatment failure with resistant species

Assessment

Differential diagnosis

  • Tuberculosis
  • Invasive fungal infection (aspergillosis)
  • Lung malignancy
  • Actinomycosis
  • Bacterial lung abscess / brain abscess

Investigations

  • Sputum/tissue microscopy and culture (modified acid-fast, prolonged incubation)
  • CT chest (nodules, cavitation, consolidation)
  • MRI/CT brain to exclude cerebral abscess (routine in disseminated/pulmonary disease)
  • Species identification and susceptibility testing
  • HIV test and immune status assessment
  • Blood cultures in disseminated disease

Management

  • Suspect in immunosuppressed patients with pulmonary and/or CNS lesions
  • Alert lab for modified acid-fast staining and prolonged culture
  • Obtain tissue/respiratory samples and species-level identification with susceptibilities
  • Image the brain in all significant/disseminated cases
  • Start empiric high-dose co-trimoxazole, often with a second agent in severe disease
  • Drain brain or other abscesses where surgically appropriate
  • Adjust therapy to species susceptibility (resistance varies widely)
  • Reduce immunosuppression where feasible
  • Give prolonged therapy (months) with longer courses for CNS/disseminated disease
  • Monitor marrow and renal function on co-trimoxazole
  • Watch for and treat relapse
  • Arrange long-term follow-up imaging

Drugs & doses

Co-trimoxazole (trimethoprim/sulfamethoxazole) 15 mg/kg/day of trimethoprim IV/PO in divided doses
Add amikacin 7.5 mg/kg IV every 12 h for severe/disseminated disease
Imipenem 500 mg IV every 6 h (combination in CNS/severe disease)
Linezolid 600 mg IV/PO twice daily (active against most species, option in sulfa allergy)

Disposition

Admit for workup and IV therapy; ID management; neurosurgery for brain abscess; long-term follow-up.

Complications & pitfalls

  • Cerebral abscess and neurological sequelae
  • Dissemination to skin, bone and other organs
  • Relapse with inadequate duration
  • Co-trimoxazole marrow/renal toxicity
  • Mortality in disseminated disease

Exam pearls

  • Always image the brain - cerebral nocardiosis is frequent and may be silent
  • Co-trimoxazole is the cornerstone; combine agents in severe disease pending susceptibilities
  • Species vary markedly in resistance; identification matters
  • Linezolid is uniformly active and oral, useful in sulfa allergy
  • Prolonged courses (6-12 months) reduce relapse, especially with CNS disease

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.